大剂量甲泼尼龙联合利妥昔单抗及新鲜冰冻血浆治疗伴有TP53基因异常的B细胞慢性淋巴增殖性疾病六例

OBJECTIVE: To investigate whether high-dose methylprednisolone with Rituximab and fresh frozen plasma (HDMP+RTX+FFP) is an effective therapy for patients with B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities. METHODS: Six B-CLPD patients with TP53 abnormalities from May...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342232/
https://www.ncbi.nlm.nih.gov/pubmed/31207703
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342232/
https://www.ncbi.nlm.nih.gov/pubmed/31207703
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.008

Ejemplares similares